Transparency Life Sciences is a new company that seeks to use open innovation to promote greater efficiency and productivity and lower the cost the development of new pharmaceuticals, as well as produce more pharmaceuticals targeted towards unmet medical needs. Open innovation has successfully been used in the technology to develop computer software and the operating system Linux, so why not medicine?
According to the founder and CEO of Transparency Life Sciences, Tomasz Sablinksi, “The main goal is lowering the cost of clinical trials so that more drugs can be delivered to the patients who need them. TLS uses crowdsourcing to incorporate the voices of as many researchers and patients as possible in the protocol design process. Then when it comes to trial execution, the use of telemedicine pushes out as much data collection to a home setting as possible. Finally, full data transparency engages the crowd’s interest and benefits the entire clinical trials ecosystem by cutting redundancy. The intended result is a better-designed trial at a lower cost.” According to their website, Transparency Life Sciences intends to lower costs by as much as 60-80%.
To read the full, original article click on this link: Transparency Life Sciences: Open-source pharma | Opinno
